Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Lydia D. Chow"'
Autor:
Lydia D Chow, Denaly Chen, Maria E. Vergara-Lluri, Eric Tam, Karrune Woan, Preet M. Chaudhary, George Yaghmour, Abdullah Ladha
Publikováno v:
Blood. 140:9027-9028
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a2da14895aaf0feaf2ea8252950f504c
https://doi.org/10.1182/blood-2022-171127
https://doi.org/10.1182/blood-2022-171127
Autor:
Sarah Alonzi, Laura M. Perry, Emma Ernst, Michael Hoerger, Lydia D. Chow, Oliver Sartor, Patrick Cotogno, Elisa Ledet, Charlotte Manogue
Publikováno v:
Support Care Cancer
PURPOSE: The present study examined the prevalence of changes in the taste and smell of food among men with advanced prostate cancer who were receiving hormone therapy and/or chemotherapy. METHOD: Participants were 75 men with advanced prostate cance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be6ef566b1a8a0bf26dec1e1749c5538
https://pubmed.ncbi.nlm.nih.gov/33566164
https://pubmed.ncbi.nlm.nih.gov/33566164
Publikováno v:
Blood. 138:1890-1890
Background Despite society recommendations to limit thrombophilia testing, this testing is often sent inappropriately. The results of thrombophilia testing frequently do not affect management. Additionally, interpretation of thrombophilia testing is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f78e05c76e63c58fd8828604f1d31638
https://doi.org/10.1182/blood-2021-151923
https://doi.org/10.1182/blood-2021-151923
Publikováno v:
Journal of Clinical Oncology. 35:201-201
201 Background: Taste alterations are a common yet frequently under-assessed problem in cancer patients. Health-related quality-of-life (HRQOL) instruments for prostate cancer (PCa) patients (pts) do not assess taste despite these hypothetically bein
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a01990ea013dacbef7df92689aa0065c
https://doi.org/10.1200/jco.2017.35.6_suppl.201
https://doi.org/10.1200/jco.2017.35.6_suppl.201
Autor:
Elizabeth A. Archie, Susan C. Alberts, Jackson H. Grady, Jeanne Altmann, Matthew N. Zipple, Lydia D. Chow, Jacob B. Gordon
Publikováno v:
Proceedings of the Royal Society B: Biological Sciences. 284:20162561
Sexually selected feticide—the death of infants in utero as a result of male behaviour—has only rarely been described or analysed, although it is presumed to be favoured by the same selective pressures that favour sexually selected infanticide. T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca6c43dcff4eeb649eae315ade4d727f
https://doi.org/10.1098/rspb.2016.2561
https://doi.org/10.1098/rspb.2016.2561
Autor:
Brian T. Hanyok, Dillon C. Cockrell, Lauren E. Howard, Christopher J. Kane, Matthew R. Cooperberg, Christopher L. Amling, Lydia D. Chow, Martha K. Terris, Rohini K. Hernandez, Daniel M. Moreira, Stephen J. Freedland, Connor L. Pratson, Katharine N. Sourbeer, William J. Aronson, Hiruni S. Amarasekara
Publikováno v:
The Journal of urology. 193(4)
We investigated imaging practice patterns in men with nonmetastatic (M0) castration resistant prostate cancer.We analyzed data on 247 patients with documented M0 CRPC from the SEARCH database. Patients were selected regardless of primary treatment mo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::baa99a182605d154601dc1db27ad4589
https://pubmed.ncbi.nlm.nih.gov/25463986
https://pubmed.ncbi.nlm.nih.gov/25463986
Autor:
A. Oliver Sartor, Allie E. Steinberger, Patrick Cotogno, Jeffrey R. Guccione, Brian E. Lewis, Elisa M. Ledet, Michael Stolten, Lydia D. Chow
Publikováno v:
Journal of Clinical Oncology. 34:249-249
249 Background: Abi and Enza are used in treating metastatic CRPC. Primary resistance is well described but little data exists for early treatment responders. Further characterization of patients with early PSA declines was the goal of this study. Me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c59cb42309d9afa5d475bb6d0db2bd6d
https://doi.org/10.1200/jco.2016.34.2_suppl.249
https://doi.org/10.1200/jco.2016.34.2_suppl.249
Publikováno v:
Journal of Clinical Oncology. 34:270-270
270 Background: Body mass index (BMI) at diagnosis is associated with increased risk of fatal prostate cancer, but the link between BMI at mCRPC and cancer progression is less clear. Cachexia, often defined as involuntary weight loss > 5% over 6 mont
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bef65fd4a9c4a113410d3bdad1c007e5
https://doi.org/10.1200/jco.2016.34.2_suppl.270
https://doi.org/10.1200/jco.2016.34.2_suppl.270